New prevalence testing requirement!
Dear Research Colleagues,
As you know Covid-19 cases continue to rise around the country and in our local community. We have an opportunity over the next three weeks to illustrate that our current research activities are operating safely and develop testing data to support maintaining our current level of research, if Commonwealth or Federal guidance will require the University to again reduce in-person activity.
As such, to protect the safety our research teams and enable the continuity of research operations, we will require COVID-19 prevalence testing for those individuals coming to Grounds as part of the previously approved research plans:
Starting on Monday, January 11th, we will ask those listed on an approved research plan to test for COVID-19 twice a week for the next three weeks and once a week starting February 1st.
- We have three locations open where you can provide a saliva sample: Central Grounds Garage, The Park at North Grounds, and MR5, Room# 2005. Please see our webpage for specific times:. https://besafe.virginia.edu/ .
The sample collection process is relatively simple.
- You should refrain from eating, drinking (including water), brushing your teeth, using mouth wash, chewing gum, or using tobacco for at least 30 minutes before submitting your saliva sample at the test location.
- Please note: If you are well hydrated, giving a saliva sample is much easier. Just refrain from drinking anything 30 minutes before doing the screening.
- You will need to bring your ID card, and know your computing ID at registration.
We are using the current research plan personnel list to send email notifications to inform research staff they need to test.
Investigators, if anyone in your lab fails to test you risk being asked to discontinue your research activity until testing requirements are met. If your personnel plan is not up to date, please update it ASAP.
If you have questions you can visit the webpage for the Research FAQ, the Be Safe webpage or email email@example.com.
We understand this is very short notice. However, we greatly appreciate your support in keeping our research efforts moving forward safely during these extremely challenging times.
Melur K. Ramasubramanian, VP for Research